

NCT02219880 comparison:

Summary:
CHIA has 22 criteria while your personal folder has 22 criteria
Total found criteria: 21/22
Total not Found: 1/22
Total Extra: 4
This trial is INVALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Aged between 18-70 years                           │ Aged between 18-70 years                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Meets the Diagnostic and Statistical Manual (DSM)  │ Meets the Diagnostic and Statistical Manual (DSM)  │
│ IV and DSM-V diagnostic criteria for generalised   │ IV and DSM-V diagnostic criteria for generalised   │
│ anxiety disorder (GAD) based on structured         │ anxiety disorder (GAD) based on structured         │
│ interview (Mini International Neuropsychiatric     │ interview (Mini International Neuropsychiatric     │
│ Interview-Plus 6 [MINI-Plus 6]. Note that while    │ Interview-Plus 6 \[MINI-Plus 6\]. Note that while  │
│ the MINI-Plus 6 uses the DSM-IV criteria, the same │ the MINI-Plus 6 uses the DSM-IV criteria, the same │
│ criteria are used in the DSM-V)                    │ criteria are used in the DSM-V)                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Presents with anxiety (Hamilton Anxiety Rating     │ Presents with anxiety (Hamilton Anxiety Rating     │
│ Scale = 18) at the time of study entry             │ Scale ≥ 18) at the time of study entry             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Fluent in written and spoken English               │ Fluent in written and spoken English               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Provides a signed copy of the consent form         │ Provides a signed copy of the consent form         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Primary diagnosis other than GAD                   │ Primary diagnosis other than GAD                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Presentation of moderate to severe depressive      │ Presentation of moderate to severe depressive      │
│ symptoms (Montgomery-Asberg Rating Scale: MADRS =  │ symptoms (Montgomery-Asberg Rating Scale: MADRS ≥  │
│ 18 at time of study entry or = 24 at any time      │ 18 at time of study entry or ≥ 24 at any time      │
│ during study)                                      │ during study)                                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Presentation of suicidal ideation (= 3 on MADRS    │ Presentation of suicidal ideation (≥ 3 on MADRS    │
│ suicidal thoughts domain at time of study entry or │ suicidal thoughts domain at time of study entry or │
│ at any time during study)                          │ at any time during study)                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current diagnosis of bipolar disorder or           │ Current diagnosis of bipolar disorder or           │
│ schizophrenia on structured interview (MINI Plus)  │ schizophrenia on structured interview (MINI Plus)  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current substance/alcohol use disorder on          │ Current substance/alcohol use disorder on          │
│ structured interview (MINI Plus) Page 21 of 39     │ structured interview (MINI Plus) Page 21 of 39     │
│ Commercial-in-Confidence                           │ Commercial-in-Confidence                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Currently taking an antidepressant, mood           │ Currently taking an antidepressant, mood           │
│ stabiliser, antipsychotic, anticonvulsant,         │ stabiliser, antipsychotic, anticonvulsant,         │
│ warfarin or thyroxin, or current regular use (more │ warfarin or thyroxin, or current regular use (more │
│ than 2 days per week) of a benzodiazepine or       │ than 2 days per week) of a benzodiazepine or       │
│ opioid-based analgesic                             │ opioid-based analgesic                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current use of a psychotropic nutraceutical (e.g.  │ Current use of a psychotropic nutraceutical (e.g.  │
│ St John's wort)                                    │ St John's wort)                                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous intolerance to kava                       │ Previous intolerance to kava                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Three or more failed trials of pharmacotherapy for │ Three or more failed trials of pharmacotherapy for │
│ the current GAD episode                            │ the current GAD episode                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Recently commenced psychotherapy (within four      │ Recently commenced psychotherapy (within four      │
│ weeks of study entry)                              │ weeks of study entry)                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Known or suspected clinically unstable systemic    │ Known or suspected clinically unstable systemic    │
│ medical disorder                                   │ medical disorder                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Diagnosed hepato-biliary disease/inflammation      │ Diagnosed hepato-biliary disease/inflammation      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Elevated liver enzymes at baseline blood test      │ Elevated liver enzymes at baseline blood test      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnancy or breastfeeding, or trying to conceive  │ Pregnancy or breastfeeding, or trying to conceive  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Not using medically approved contraception         │ Not using medically approved contraception         │
│ (including abstinence) if female and of            │ (including abstinence) if female and of            │
│ childbearing age                                   │ childbearing age                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Unable to participate in all scheduled visits,     │ Unable to participate in all scheduled visits,     │
│ treatment plan, or other trial procedures          │ treatment plan, or other trial procedures          │
│ according to the protocol (except for the optional │ according to the protocol (except for the optional │
│ genetic component)                                 │ genetic component)                                 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



╒═══════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal   │
╞═══════════════════════════════════════╡
│ NA                                    │
╘═══════════════════════════════════════╛



╒═══════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                           │
╞═══════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Participants are ineligible to enter the trial if they have any of the following conditions       │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have maximum age of 70 Years                                                                 │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                 │
├───────────────────────────────────────────────────────────────────────────────────────────────────┤
│ To be considered for inclusion in this study, participants will be required to meet the following │
│ criteria                                                                                          │
╘═══════════════════════════════════════════════════════════════════════════════════════════════════╛